[1]
S. A. Kumar and R. C. C. V., “Investigational synthetic neuroactive steroid zuranolone in treatment of major depressive disorder with peripartum onset”, Int J Basic Clin Pharmacol, vol. 11, no. 3, pp. 275–278, Apr. 2022.